These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9270424)

  • 1. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions.
    Ball SS; Prazma J; Dais CG; Triana RJ; Pillsbury HC
    Ann Otol Rhinol Laryngol; 1997 Aug; 106(8):633-9. PubMed ID: 9270424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide: a mediator of endotoxin-induced middle ear effusions.
    Ball SS; Prazma J; Dais D; Rosbe KW; Pillsbury HC
    Laryngoscope; 1996 Aug; 106(8):1021-7. PubMed ID: 8699894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of IL-1, IL-6, and TNFalpha in the feeding responses to endotoxin and influenza virus infection in mice.
    Swiergiel AH; Dunn AJ
    Brain Behav Immun; 1999 Sep; 13(3):252-65. PubMed ID: 10469526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhibitor of tumor necrosis factor-alpha on experimental otitis media with effusion.
    Jeon EJ; Park YS; Choi YC; Yeo SW; Jung TT
    Ann Otol Rhinol Laryngol; 2001 Oct; 110(10):917-21. PubMed ID: 11642423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interleukin-1beta in a murine model of otitis media with effusion.
    Watanabe T; Hirano T; Suzuki M; Kurono Y; Mogi G
    Ann Otol Rhinol Laryngol; 2001 Jun; 110(6):574-80. PubMed ID: 11407850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
    Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
    J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.
    Kimble RB; Matayoshi AB; Vannice JL; Kung VT; Williams C; Pacifici R
    Endocrinology; 1995 Jul; 136(7):3054-61. PubMed ID: 7789332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumor necrosis factor-alpha on experimental otitis media with effusion.
    Lee DH; Park YS; Jung TT; Yeo SW; Choi YC; Jeon E
    Laryngoscope; 2001 Apr; 111(4 Pt 1):728-33. PubMed ID: 11359148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide.
    Lodato RF; Khan AR; Zembowicz MJ; Weisbrodt NW; Pressley TA; Li YF; Lodato JA; Zembowicz A; Moody FG
    Am J Physiol; 1999 Jun; 276(6):G1356-62. PubMed ID: 10362638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance.
    Colagiovanni DB; Shopp GM
    Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):397-419. PubMed ID: 8872492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of mucous cell metaplasia by tumor necrosis factor alpha in rat middle ear: the pathological basis for mucin hyperproduction in mucoid otitis media.
    Kawano H; Haruta A; Tsuboi Y; Kim Y; Schachern PA; Paparella MM; Lin J
    Ann Otol Rhinol Laryngol; 2002 May; 111(5 Pt 1):415-22. PubMed ID: 12018326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion.
    Kim DH; Park YS; Jeon EJ; Yeo SW; Chang KH; Lee SK
    Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):617-23. PubMed ID: 16944661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tumor necrosis factor binding protein and interleukin-1 receptor antagonist on the development of abdominal aortic aneurysms in a rat model.
    Hingorani A; Ascher E; Scheinman M; Yorkovich W; DePippo P; Ladoulis CT; Salles-Cunha S
    J Vasc Surg; 1998 Sep; 28(3):522-6. PubMed ID: 9737463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin and tumor necrosis factor-alpha in middle ear effusions in relation to upper airway infection.
    Nell MJ; Grote JJ
    Laryngoscope; 1999 Nov; 109(11):1815-9. PubMed ID: 10569413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of Regulatory T Cells and Chronic Inflammation in the Middle Ear in a Mouse Model of Chronic Otitis Media with Effusion Induced by Combined Eustachian Tube Blockage and Nontypeable Haemophilus influenzae Infection.
    Hirano T; Kodama S; Kawano T; Suzuki M
    Infect Immun; 2016 Jan; 84(1):356-64. PubMed ID: 26553466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucin production in the middle ear in response to lipopolysaccharides.
    Hunter SE; Singla AK; Prazma J; Jewett BS; Randell SH; Pillsbury HC
    Otolaryngol Head Neck Surg; 1999 Jun; 120(6):884-8. PubMed ID: 10352444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interleukin-1 in endotoxin-induced lung injury in the rat.
    Rose CE; Juliano CA; Tracey DE; Yoshimura T; Fu SM
    Am J Respir Cell Mol Biol; 1994 Feb; 10(2):214-21. PubMed ID: 8110477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor.
    Maxwell K; Leonard G; Kreutzer DL
    Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):984-8. PubMed ID: 9305251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Surfactant Protein-A during LPS-Induced Otitis Media with Effusion in Mice.
    Li L; Guo X; Olszewski E; Fan Z; Ai Y; Han Y; Xu L; Li J; Wang H
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):433-9. PubMed ID: 26048420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response to human rIL-1, rIL-2, and rTNF in the middle ear of guinea pigs.
    Catanzaro A; Ryan A; Batcher S; Wasserman SI
    Laryngoscope; 1991 Mar; 101(3):271-5. PubMed ID: 2000014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.